| Alcohol and substance use diagnoses among HIV-positive patients receiving care in NYC clinic settings S Gurung, A Ventuneac, D Cain, C Mirzayi, C Ferraris, HJ Rendina, ... Drug and alcohol dependence 180, 62-67, 2017 | 17 | 2017 |
| Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in South Africa L Jennings, RN Robbins, N Nguyen, C Ferraris, CS Leu, C Dolezal, ... Aids 36 (7), 933-940, 2022 | 13 | 2022 |
| Mobile screening to identify and follow-up with high risk, HIV negative youth ID Aronson, CM Cleland, DC Perlman, S Rajan, W Sun, C Ferraris, ... Journal of mobile technology in medicine 5 (1), 9, 2016 | 8 | 2016 |
| Effectiveness of a combined motivational interviewing and cognitive behavioral intervention to reduce substance use and improve HIV-related immune functioning TJ Starks, SJ Skeen, S Scott Jones, S Gurung, BM Millar, C Ferraris, ... AIDS and Behavior, 1-15, 2022 | 5 | 2022 |
| Adaptation and construct validity evaluation of a tablet-based, short neuropsychological test battery for use with adolescents and young adults living with HIV in Thailand. RN Robbins, AF Santoro, C Ferraris, N Asiedu, J Liu, C Dolezal, ... Neuropsychology 36 (8), 695, 2022 | 2 | 2022 |
| The importance of domain-specific self-efficacy assessment for substance use and HIV care continuum outcomes among adults in an urban HIV clinic network TJ Starks, SJ Skeen, SS Jones, BM Millar, S Gurung, C Ferraris, ... AIDS care 34 (5), 670-678, 2022 | 2 | 2022 |
| Evaluating the implementation of an efficacious HIV intervention program for hazardous drinkers in care clinic centers in NYC S Gurung, C Ferraris, MA Sparks, A Ventuneac, JT Parsons, TJ Starks PSYCHOSOMATIC MEDICINE 81 (4), A84-A84, 2019 | 1 | 2019 |
| 71 Examining the Psychometric Validity of NeuroScreen to Assess Neurocognition in Hospitalized Psychosis Patients in Uganda N Asiedu, C Morrison, C Kirsch, R Dunayev, N Kanaan, C Ferraris, ... Journal of the International Neuropsychological Society 29 (s1), 855-856, 2023 | | 2023 |
| Comparing Predictive Ability of Two Objective Adherence Measures in a Community-Based Cohort on Antiretroviral Therapy in South Africa: Tenofovir Diphosphate Concentrations and … L Jennings, CM Ferraris, JR Castillo-Mancilla, RN Robbins, N Nguyen, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 93 (4), 327-332, 2023 | | 2023 |
| Acceptability and Feasibility of Genetic Testing to Assess Risk of HIV-Associated Neurocognitive Impairment among Thai Adolescents and Young Adults AF Santoro, CM Ferraris, M Aghvinian, L Aurpibul, D Kolson, RN Robbins AIDS Research and Human Retroviruses 39 (6), 294-301, 2023 | | 2023 |
| Acceptability of a tablet application to assess neurocognitive functioning in a resource limited setting CM Ferraris, AF Santoro, D Tsapalas, N Asiedu, N Phillips, J Hoare, ... TMS Proceedings 2021, 2021 | | 2021 |
| 80. Heme Oxygenase-1 Gene promoter and associations with inflammation and subclinical vascular disease in Ugandan adolescents with and without HIV S Dirajlal-Fargo, A Sattar, V Musiime, C Kityo, RN Robbins, AF Santoro, ... Open Forum Infectious Diseases 8 (Supplement_1), S52-S52, 2021 | | 2021 |
| Sexual risk behaviors and behavioral problems among youth with perinatally acquired HIV in Thailand D Tsapalas, A Santoro, N Asiedu, C Ferraris, L Aurpibul, RN Robbins APHA 2021 Annual Meeting and Expo, 2021 | | 2021 |
| A-6 Childhood Adversity’s Impact on Neurocognitive Functioning: Findings from South African Adolescents Living with HIV AF Santoro, C Ferraris, N Phillips, J Hoare, RN Robbins Archives of Clinical Neuropsychology 36 (6), 1027-1028, 2021 | | 2021 |
| EVALUATING EFFECTIVENESS OF A TAILORED SUBSTANCE USE INTERVENTION FOR PEOPLE WITH HIV: IMPLEMENTATION OF PLUS IN NYC HIV CLINICS TJ Starks, SS Jones, S Gurung, CM Ferraris, A Ventuneac, JT Parsons, ... ANNALS OF BEHAVIORAL MEDICINE 54, S325-S325, 2020 | | 2020 |
